For: | Ren N, Ye QH, Qin LX, Zhang BH, Liu YK, Tang ZY. Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. World J Gastroenterol 2006; 12(24): 3911-3914 [PMID: 16804981 DOI: 10.3748/wjg.v12.i24.3911] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i24/3911.htm |
Number | Citing Articles |
1 |
Wim Laureyn, Tim Stakenborg, Paul Jacobs. Handbook of Biosensors and Biochips. 2007; doi: 10.1002/9780470061565.hbb111
|
2 |
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
|
3 |
Alberto Ocaña, Laura Díez-González, Dolores C. García-Olmo, Arnoud J. Templeton, Francisco Vera-Badillo, María José Escribano, Gemma Serrano-Heras, Verónica Corrales-Sánchez, Bostjan Seruga, Fernando Andrés-Pretel, Atanasio Pandiella, Eitan Amir. Circulating DNA and Survival in Solid Tumors. Cancer Epidemiology, Biomarkers & Prevention 2016; 25(2): 399 doi: 10.1158/1055-9965.EPI-15-0893
|
4 |
Amir Hossein Aalami, Farnoosh Aalami, Ehsan Kargar Aliabadi, Amir Amirabadi, Amirhossein Sahebkar. Detection of Circulating Cell-free DNA to Diagnose Hepatocellular
Carcinoma in Chinese Population: A Systematic Review and
Meta-analysis. Current Medicinal Chemistry 2024; 31(22): 3345 doi: 10.2174/0929867330666230622114235
|
5 |
Yu-Jie Gao, Yu-Juan He, Zai-Lin Yang, Hui-Yuan Shao, Yan Zuo, Yao Bai, Hui Chen, Xian-Chun Chen, Feng-Xian Qin, Shi Tan, Jian Wang, Li Wang, Ling Zhang. Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia. cclm 2010; 48(11): 1651 doi: 10.1515/CCLM.2010.311
|
6 |
恳 陈. Detection and Application of Circulating-Free Cell DNA in Hepatopathy. Medical Diagnosis 2013; 3(01): 10 doi: 10.12677/MD.2013.31003
|
7 |
Michele Dal Bo, Elena De Mattia, Lorena Baboci, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf, Giuseppe Toffoli. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 2020; 51: 100702 doi: 10.1016/j.drup.2020.100702
|
8 |
Raphaël Saffroy, Patrick Pham, Maâmar Reffas, Mohamed Takka, Antoinette Lemoine, Brigitte Debuire. New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clinical Chemical Laboratory Medicine 2007; 45(9) doi: 10.1515/CCLM.2007.262
|
9 |
Juan Wang, Liu Yang, Yanjun Diao, Jiayun Liu, Jinjie Li, Rui Li, Lianghong Zheng, Kang Zhang, Yueyun Ma, Xiaoke Hao. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR. Journal of International Medical Research 2021; 49(3) doi: 10.1177/0300060521992962
|
10 |
Hon-Fan Lai, Shin-E Wang, Shih-Chin Chen, Bor-Shiuan Shyr, Yi-Ming Shyr, Bor-Uei Shyr. The emerging role of cell-free DNA as a molecular marker for duodenal adenocarcinoma. Journal of the Chinese Medical Association 2024; 87(4): 422 doi: 10.1097/JCMA.0000000000001079
|
11 |
Farzaneh Banki, Wael N. Yacoub, Jeffrey A. Hagen, Rodney J. Mason, Shahin Ayazi, Steven R. DeMeester, John C. Lipham, Kathleen Danenberg, Peter Danenberg, Tom R. DeMeester. Plasma DNA Is More Reliable than Carcinoembryonic Antigen for Diagnosis of Recurrent Esophageal Cancer. Journal of the American College of Surgeons 2008; 207(1): 30 doi: 10.1016/j.jamcollsurg.2008.01.004
|
12 |
Franziska Hauth, Hannah J. Roberts, Theodore S. Hong, Dan G. Duda. Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers. International Journal of Molecular Sciences 2022; 23(4): 1926 doi: 10.3390/ijms23041926
|
13 |
Dolores C. García-Olmo, Julia Samos, María G. Picazo, Ana I. Asensio, Inmaculada Toboso, Damián García-Olmo. Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in rats. Cancer Letters 2008; 272(1): 133 doi: 10.1016/j.canlet.2008.07.003
|
14 |
Jian Zhou, Ao Huang, Xin-Rong Yang. Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 2016; 47(2): 157 doi: 10.1007/s12029-016-9801-0
|
15 |
Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, Eric Miller, Ashish Manne. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?. International Journal of Molecular Sciences 2023; 24(18): 14231 doi: 10.3390/ijms241814231
|
16 |
Paola Ulivi, Rosella Silvestrini. Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer. Cellular Oncology 2013; 36(6): 439 doi: 10.1007/s13402-013-0155-3
|
17 |
Sherien F. El-Shazly, Manal A. Eid, Hesham A. El-Sourogy, Gehan F. Attia, Sherif A. Ezzat. Evaluation of Serum Dna Integrity as a Screening and Prognostic Tool in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma. The International Journal of Biological Markers 2010; 25(2): 79 doi: 10.1177/172460081002500204
|
18 |
Marianna Alunni-Fabbroni, Sabine Weber, Osman Öcal, Max Seidensticker, Julia Mayerle, Peter Malfertheiner, Jens Ricke. Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis. Cancers 2021; 13(3): 521 doi: 10.3390/cancers13030521
|
19 |
Patrick Kirchweger, Helwig Valentin Wundsam, Holger Rumpold. Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies. World Journal of Clinical Oncology 2022; 13(6): 473-484 doi: 10.5306/wjco.v13.i6.473
|
20 |
Sridhar Mishra, Swati Kumari, Nuzhat Husain. Liquid Biopsy in Gallbladder Carcinoma: Current Evidence and Future Prospective. The Journal of Liquid Biopsy 2024; : 100280 doi: 10.1016/j.jlb.2024.100280
|
21 |
Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven Curley, Yuman Fong, Gregory Gores, Robert Kerlan, Phillipe Merle, Bert O'Neil, Ronnie Poon, Lawrence Schwartz, Joel Tepper, Francis Yao, Daniel Haller, Margaret Mooney, Alan Venook. Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting. Journal of Clinical Oncology 2010; 28(25): 3994 doi: 10.1200/JCO.2010.28.7805
|
22 |
Marika Piciocchi, Romilda Cardin, Alessandro Vitale, Veronica Vanin, Anna Giacomin, Caterina Pozzan, Gemma Maddalo, Umberto Cillo, Maria Guido, Fabio Farinati. Circulating free DNA in the progression of liver damage to hepatocellular carcinoma. Hepatology International 2013; 7(4): 1050 doi: 10.1007/s12072-013-9481-9
|
23 |
Hugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera. Liquid biopsy in chronic liver disease. Annals of Hepatology 2021; 20: 100197 doi: 10.1016/j.aohep.2020.03.008
|
24 |
S. Garg, A. Kumar, R. Gupta. Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA. Clinical and Translational Oncology 2021; 23(11): 2206 doi: 10.1007/s12094-021-02635-4
|
25 |
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary Malignancies. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
|
26 |
Chang-Qing Yin, Chun-Hui Yuan, Zhen Qu, Qing Guan, Hao Chen, Fu-Bing Wang. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers. Disease Markers 2016; 2016: 1 doi: 10.1155/2016/1427849
|
27 |
Klaus Jung, Michael Fleischhacker, Anja Rabien. Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature. Clinica Chimica Acta 2010; 411(21-22): 1611 doi: 10.1016/j.cca.2010.07.032
|
28 |
Sangjoon Park, Eun Jung Lee, Chai Hong Rim, Jinsil Seong. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma. Yonsei Medical Journal 2018; 59(4): 470 doi: 10.3349/ymj.2018.59.4.470
|
29 |
Jessica A. Howell, Shahid A. Khan, Susanne Knapp, Mark R. Thursz, Rohini Sharma. The clinical role of circulating free tumor DNA in gastrointestinal malignancy. Translational Research 2017; 183: 137 doi: 10.1016/j.trsl.2016.12.006
|
30 |
Yan-yan Yan, Qiao-ru Guo, Feng-hua Wang, Rameshwar Adhikari, Zhuang-yan Zhu, Hai-yan Zhang, Wen-min Zhou, Hua Yu, Jing-quan Li, Jian-ye Zhang. Cell-Free DNA: Hope and Potential Application in Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.639233
|
31 |
Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang. Liquid biopsy in pancreatic cancer: the beginning of a new era. Oncotarget 2018; 9(42): 26900 doi: 10.18632/oncotarget.24809
|
32 |
Haiwei Li, Songqi Zhang, Ruochen Zhu, Zheng Zhou, Lu Xia, Hao Lin, Shuo Chen. Early assessment of chemotherapeutic response in hepatocellular carcinoma based on serum surface-enhanced Raman spectroscopy. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2022; 278: 121314 doi: 10.1016/j.saa.2022.121314
|
33 |
Roberto A. Perego, Matteo Corizzato, Paola Brambilla, Stefano Ferrero, Cristina Bianchi, Ester Fasoli, Stefano Signorini, Barbara Torsello, Lara Invernizzi, Silvia Bombelli, Valentina Angeloni, Marina Pitto, Cristina Battaglia, Vanessa Proserpio, Fulvio Magni, Giacomo Galasso, Paolo Mocarelli. Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma. European Journal of Cancer 2008; 44(7): 1039 doi: 10.1016/j.ejca.2008.03.008
|
34 |
Jessica A Howell, Rohini Sharma. The clinical role of ‘liquid biopsy’ in hepatocellular carcinoma. Hepatic Oncology 2016; 3(1): 45 doi: 10.2217/hep.15.38
|
35 |
Claire Faltermeier, Ronald Busuttil, Ali Zarrinpar. A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases 2015; 3(4): 221 doi: 10.3390/diseases3040221
|
36 |
Zhaohui Huang, Dong Hua, Yu Hu, Zhihong Cheng, Xike Zhou, Qigen Xie, Qiongyao Wang, Feng Wang, Xiang Du, Yanjun Zeng. Quantitation of Plasma Circulating DNA Using Quantitative PCR for the Detection of Hepatocellular Carcinoma. Pathology & Oncology Research 2012; 18(2): 271 doi: 10.1007/s12253-011-9438-z
|
37 |
Wendy V Jaraba Álvarez, Isaura P. Torres Gómez, Rubén D. Manrique Hernández, Juan E Gallo Bonilla. Estado actual de las aplicaciones del ADN libre de célula circulante. Medicina y Laboratorio 2017; 23(11-12): 551 doi: 10.36384/01232576.6
|
38 |
Chih-Lin Lin, Jia-Horng Kao. Hepatitis B Virus and Liver Disease. 2021; : 231 doi: 10.1007/978-981-16-3615-8_10
|
39 |
Onyinye Ugonabo, Utibe-Abasi Sunday Udoh, Pradeep Kumar Rajan, Heather Reeves, Christina Arcand, Yuto Nakafuku, Tejas Joshi, Rob Finley, Sandrine V. Pierre, Juan Ramon Sanabria. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions. Biomolecules 2023; 13(9): 1369 doi: 10.3390/biom13091369
|
40 |
Nikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, Jürgen Durner, Petra Stieber, Stefan Holdenrieder. Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy. Tumor Biology 2012; 33(1): 33 doi: 10.1007/s13277-011-0237-7
|
41 |
Yahya Elshimali, Husseina Khaddour, Marianna Sarkissyan, Yanyuan Wu, Jaydutt Vadgama. The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients. International Journal of Molecular Sciences 2013; 14(9): 18925 doi: 10.3390/ijms140918925
|
42 |
Klara Cervena, Pavel Vodicka, Veronika Vymetalkova. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review. Mutation Research/Reviews in Mutation Research 2019; 781: 100 doi: 10.1016/j.mrrev.2019.05.002
|
43 |
Dolores C García-Olmo, María G Picazo, Inmaculada Toboso, Ana I Asensio, Damián García-Olmo. Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats. Molecular Cancer 2013; 12(1) doi: 10.1186/1476-4598-12-8
|
44 |
Silvia Mezzalira, Elena De Mattia, Michela Guardascione, Chiara Dalle Fratte, Erika Cecchin, Giuseppe Toffoli. Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes. International Journal of Molecular Sciences 2019; 20(21): 5498 doi: 10.3390/ijms20215498
|
45 |
Pengjun Zhang, Xinyu Wen, Feng Gu, Xinxin Deng, Juan Li, Jin Dong, Jiao Jiao, Yaping Tian. Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip. Hepatology International 2013; 7(3): 893 doi: 10.1007/s12072-013-9437-0
|